公司資料
Treace Medical Concepts 股價、新聞與催化劑
- 股票代碼:
- TMCI
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股票表現
4.50 USD (-6.05%)
收盤價
最後更新: 2026年8月17日
225M USD
市值
股價為何變動
As of Aug 17, 2026, TMCI closed down 6.05% at $4.50. No new same-company headline was identified in the current news window.
公司概覽
Bunion and Midfoot Surgery
Treace Medical Concepts develops orthopedic systems for the surgical correction of bunions and related midfoot deformities. Its products are designed to address the underlying three-dimensional alignment of the affected anatomy.
Lapiplasty Platform
The Lapiplasty procedure and associated instrumentation enable surgeons to correct and stabilize the metatarsal in multiple planes. Treace has expanded the platform with implants and tools covering a broader range of bunion presentations. The company sells single-use implants and instruments through a specialized field organization, supported by surgeon training and a growing installed base of reusable surgical equipment.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。